Abu Dhabi, United Arab Emirates, 22 June 2026: Burjeel Holdings PLC (“Burjeel” or “the Group”), a leading super-specialty healthcare services provider in the GCC listed on the Abu Dhabi Securities Exchange (SYMBOL: BURJEEL; ISIN: AEE01119B224), today announced that it has received first-time corporate credit ratings from S&P Global Ratings and Moody’s Ratings, alongside the establishment of a USD 1.5 billion Senior Unsecured Sukuk Programme.

The assignment of ratings marks an important milestone for Burjeel Holdings and reflects the Group’s robust business profile, disciplined financial policy, strong corporate governance and continued commitment to transparency.

The Sukuk Programme has been established through Burjeel Sukuk Limited, a special purpose vehicle established for this purpose, and is admitted to the London Stock Exchange’s International Securities Market. The Programme provides Burjeel Holdings with a flexible Shariah-compliant platform to access debt capital markets, supporting the Group’s strategy to diversify funding sources, strengthen its long-term capital structure and pursue strategic investments in advanced clinical care, research, medical education, digital transformation and AI-enabled healthcare innovation.

S&P Global Ratings

BB+, Stable outlook

Moody’s Ratings

Ba2, Stable outlook

Burjeel Holdings continues to benefit from favourable long-term healthcare fundamentals in the UAE and the wider GCC, including demographic growth, mandatory health insurance coverage, increasing demand for specialised care, and the region’s continued development as a medical tourism hub. The Group’s integrated network, multi-brand model, and focus on advanced clinical capabilities position it to serve a broad patient base across primary, secondary, tertiary, and quaternary care.

Receiving first-time ratings from two of the world’s leading credit rating agencies is an important milestone for Burjeel Holdings and reflects the strength of our platform, our disciplined financial policy, strong corporate governance and the resilience of our operating model. The establishment of our Sukuk Programme further enhances our financial flexibility and supports our strategy to diversify funding sources while maintaining prudent leverage and strong liquidity.

We are building a healthcare platform for the future, one that integrates exceptional patient care with research, education, and artificial intelligence. This milestone strengthens our ability to pursue that vision while maintaining financial discipline, creating long-term value, and supporting the UAE’s ambition to become a global centre for healthcare excellence and innovation.

In connection with the Sukuk Programme, Burjeel Holdings has initiated a series of fixed income investor meetings with regional and international investors in relation to a potential inaugural Regulation S USD benchmark 5-year senior unsecured Sukuk offering. Any such offering, if undertaken, would be subject to market conditions, applicable regulatory requirements and the publication of the relevant offering documents.

The credit reports are available on the S&P Global (>https://www.spglobal.com/ratings/) and Moody’s (https://www.moodys.com/) websites.

Burjeel Holdings Assigned BB+ by S&P and Ba2 by Moody’s; Establishes USD 1.5 Billion Sukuk Programme